FUJIFILM Diosynth Biotechnologies joined the Fujifilm group in 2011. The company operates as a biopharmaceutical contract manufacturing organization that works with international pharmaceutical and biotechnology customers to develop safe, cost efficient manufacturing processes for therapeutic medicines. The company is based in Billingham in North East England and North Carolina, USA.
Drugs based on proteins that are naturally generated by the human body are more readily tolerated and have fewer side effects. The growth of the biopharmaceutical market is outpacing conventional chemical-based drugs and about 8 of the top 10 selling drugs are expected to be biopharmaceuticals in 5 years or so. The investment into biopharmaceutical production is part of Fujifilm’s strategy to establish a comprehensive healthcare business with prevention, diagnosis and treatment, enhancing the lives of people worldwide. A recent article in Pharmaceutical Technology provides an insight into this business.
More Information / Link to FUJIFILM Diosynth
Categories: Spotlight - Information about FUJIFILM Europe